Endocrinology, Vol 133, 1562-1568, Copyright © 1993 by Endocrine Society

ARTICLES

Mechanism of pervanadate stimulation and potentiation of insulin- activated glucose transport in rat adipocytes: dissociation from vanadate effect

A Shisheva and Y Shechter
Department of Hormone Research, Weizmann Institute of Science, Rehovot, Israel.

Previous studies have shown that the combination of vanadate and H2O2 generates peroxide(s) of vanadate (pervanadate) that is able to mimic insulin in stimulating lipogenesis or protein synthesis and inhibiting lipolysis in rat adipocytes. Here we report that pervanadate is a potent trigger of 3-O-methylglucose transport in rat adipocytes, with an effective concentration of 5 microM and a maximum at 20 microM. Moreover, pervanadate produced an additional activation of approximately 60% on glucose influx in cells treated with maximally activating concentrations of insulin. Vanadate was ineffective in potentiating insulin-stimulated glucose uptake. Quercetin, a bioflavonoid that inhibits insulin receptor tyrosine kinase, blunted this effect of pervanadate. Treatment of adipocytes with pervanadate inhibited protein phosphotyrosyl phosphatase activity of cell extracts in a dose-dependent manner, with an ID50 of 5 microM and complete inhibition at 80 microM. In contrast, vanadate (1-800 microM) did not appreciably inhibit cell phosphotyrosyl phosphatases. The inhibitory effect of pervanadate correlated with the increase in protein phosphotyrosine accumulation, as determined by Western blotting with antiphosphotyrosine antibodies. The most prominent phosphotyrosine- containing band detected in pervanadate-treated adipocytes was that of autophosphorylated insulin receptor, identified by immunoblotting or immunoprecipitation with antiinsulin receptor antibodies. The addition of insulin to pervanadate-treated adipocytes (20 microM) caused a further increase (approximately 70%) in receptor autophosphorylation. In a cell-free system using partially purified insulin receptor devoid of tyrosine phosphatase activity, pervanadate did not stimulate the receptor autophosphorylation or interfere with the stimulating effect of insulin. These results suggest that 1) pervanadate triggers glucose uptake by increasing autophosphorylation of insulin receptor, preventing its dephosphorylation; 2) under physiological conditions, cellular protein phosphotyrosyl phosphatase activity is high, thereby significantly opposing insulin-mediated hexose transport; and 3) pervanadate has the unique ability to markedly increase maximal cell responsiveness in stimulating glucose transport achieved at a saturating insulin concentration. These findings suggest a possible clinical application in the management of glucose uptake in pathological conditions of insulin resistance and hyperinsulinemia.

This article has been cited by other articles:

				L. H. Abdullah and C. W. Davis Regulation of airway goblet cell mucin secretion by tyrosine phosphorylation signaling pathways Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L591 - L599. [Abstract] [Full Text] [PDF]

				S. Bose, M A. Farah, H.-C. Jung, J.-H. Lee, and Y. Kim Molecular mechanism of bis(maltolato)oxovanadium(IV)-induced insulin signaling in 3T3-L1 and IM9 cells: impact of dexamethasone J. Mol. Endocrinol., June 1, 2007; 38(6): 627 - 649. [Abstract] [Full Text] [PDF]

				A. Abella, L. Marti, M. Camps, M. Claret, J. Fernandez-Alvarez, R. Gomis, A. Guma, N. Viguerie, C. Carpene, M. Palacin, et al. Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein-1 Activity Exerts an Antidiabetic Action in Goto-Kakizaki Rats Diabetes, April 1, 2003; 52(4): 1004 - 1013. [Abstract] [Full Text] [PDF]

				L. Marti, A. Abella, C. Carpene, M. Palacin, X. Testar, and A. Zorzano Combined Treatment With Benzylamine and Low Dosages of Vanadate Enhances Glucose Tolerance and Reduces Hyperglycemia in Streptozotocin-Induced Diabetic Rats Diabetes, September 1, 2001; 50(9): 2061 - 2068. [Abstract] [Full Text] [PDF]

				N. Morin, J.-M. Lizcano, E. Fontana, L. Marti, F. Smih, P. Rouet, D. Prévot, A. Zorzano, M. Unzeta, and C. Carpéné Semicarbazide-Sensitive Amine Oxidase Substrates Stimulate Glucose Transport and Inhibit Lipolysis in Human Adipocytes J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 563 - 572. [Abstract] [Full Text]

				L. Marti, N. Morin, G. Enrique-Tarancon, D. Prevot, M. Lafontan, X. Testar, A. Zorzano, and C. Carpéné Tyramine and Vanadate Synergistically Stimulate Glucose Transport in Rat Adipocytes by Amine Oxidase-Dependent Generation of Hydrogen Peroxide J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 342 - 349. [Abstract] [Full Text]

				C. J. Band, B. I. Posner, V. Dumas, and J.-O. Contreres Early Signaling Events Triggered by Peroxovanadium [bpV(phen)] Are Insulin Receptor Kinase (IRK)-Dependent: Specificity of Inhibition of IRK-Associated Protein Tyrosine Phosphatase(s) by bpV(phen) Mol. Endocrinol., December 1, 1997; 11(13): 1899 - 1910. [Abstract] [Full Text] [PDF]

				J. Li, G. Elberg, N. Sekar, Z. B. He, and Y. Shechter Antilipolytic Actions of Vanadate and Insulin in Rat Adipocytes Mediated by Distinctly Different Mechanisms Endocrinology, June 1, 1997; 138(6): 2274 - 2279. [Abstract] [Full Text] [PDF]

				A. Cadène, F. Grigorescu, J.-J. Serrano, and G. Cros Characterization of Vanadyl Sulfate Effect on Vascular Contraction: Roles of Calcium and Tyrosine Phosphorylation J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 491 - 498. [Abstract] [Full Text]

				Z. Zhao, Z. Tan, C. D. Diltz, M. You, and E. H. Fischer Activation of Mitogen-activated Protein (MAP) Kinase Pathway by Pervanadate, a Potent Inhibitor of Tyrosine Phosphatases J. Biol. Chem., September 6, 1996; 271(36): 22251 - 22255. [Abstract] [Full Text] [PDF]

				A. Shisheva, B. Rusin, O. C. Ikonomov, C. DeMarco, and D. Sbrissa Localization and Insulin-regulated Relocation of Phosphoinositide 5-Kinase PIKfyve in 3T3-L1 Adipocytes J. Biol. Chem., April 6, 2001; 276(15): 11859 - 11869. [Abstract] [Full Text] [PDF]